Check-Cap Ltd. (Check-Cap) is a clinical-stage medical diagnostics company. The Company is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for colorectal cancer (CRC) screening. The Company’s imaging capsule is designed to create a reconstructed two and three-dimensional image of the colon and to enable detection of clinical polyps. The Company’s imaging capsule consists of an X-ray source and X-ray detectors. The X-ray source is contained in a rotating radiation shield, enabling the generation of 360-degree angular scans. The Company’s imaging capsule is swallowed by the patient and propelled by natural motility through the gastrointestinal tract and excreted naturally. Its imaging capsule employs X-rays, which allow it to image the lining of the colon even when surrounded by intestinal content.
